COVID-19 Impact on Global HER2 Antibody, Market Insights and Forecast to 2026
HER2 Antibody market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HER2 Antibody market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the HER2 Antibody market is segmented into
The HER2 Antibody market is analysed and market size information is provided by regions (countries).
The key regions covered in the HER2 Antibody market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and HER2 Antibody Market Share Analysis
HER2 Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HER2 Antibody business, the date to enter into the HER2 Antibody market, HER2 Antibody product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the HER2 Antibody market is segmented into
- Trastuzumab
- Lapatinib
- Ado-trastuzumab Emtansine
- Pertuzumab
- Everolimus
- Hospital
- Medical Center
The HER2 Antibody market is analysed and market size information is provided by regions (countries).
The key regions covered in the HER2 Antibody market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and HER2 Antibody Market Share Analysis
HER2 Antibody market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in HER2 Antibody business, the date to enter into the HER2 Antibody market, HER2 Antibody product introduction, recent developments, etc.
The major vendors covered:
- Genentech Inc
- Novartis AG
- Pfizer
- Abnova Corporation
- InvivoGen
- Celltrion
- Biocon Limited
- Bio-Techne
1 STUDY COVERAGE
1.1 HER2 Antibody Product Introduction
1.2 Market Segments
1.3 Key HER2 Antibody Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global HER2 Antibody Market Size Growth Rate by Type
1.4.2 Trastuzumab
1.4.3 Lapatinib
1.4.4 Ado-trastuzumab Emtansine
1.4.5 Pertuzumab
1.4.6 Everolimus
1.5 Market by Application
1.5.1 Global HER2 Antibody Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Center
1.6 Coronavirus Disease 2019 (Covid-19): HER2 Antibody Industry Impact
1.6.1 How the Covid-19 is Affecting the HER2 Antibody Industry
1.6.1.1 HER2 Antibody Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and HER2 Antibody Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for HER2 Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global HER2 Antibody Market Size Estimates and Forecasts
2.1.1 Global HER2 Antibody Revenue 2015-2026
2.1.2 Global HER2 Antibody Sales 2015-2026
2.2 HER2 Antibody Market Size by Region: 2020 Versus 2026
2.2.1 Global HER2 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global HER2 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HER2 ANTIBODY COMPETITOR LANDSCAPE BY PLAYERS
3.1 HER2 Antibody Sales by Manufacturers
3.1.1 HER2 Antibody Sales by Manufacturers (2015-2020)
3.1.2 HER2 Antibody Sales Market Share by Manufacturers (2015-2020)
3.2 HER2 Antibody Revenue by Manufacturers
3.2.1 HER2 Antibody Revenue by Manufacturers (2015-2020)
3.2.2 HER2 Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2019
3.2.5 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 HER2 Antibody Price by Manufacturers
3.4 HER2 Antibody Manufacturing Base Distribution, Product Types
3.4.1 HER2 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HER2 Antibody Product Type
3.4.3 Date of International Manufacturers Enter into HER2 Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global HER2 Antibody Market Size by Type (2015-2020)
4.1.1 Global HER2 Antibody Sales by Type (2015-2020)
4.1.2 Global HER2 Antibody Revenue by Type (2015-2020)
4.1.3 HER2 Antibody Average Selling Price (ASP) by Type (2015-2026)
4.2 Global HER2 Antibody Market Size Forecast by Type (2021-2026)
4.2.1 Global HER2 Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global HER2 Antibody Revenue Forecast by Type (2021-2026)
4.2.3 HER2 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global HER2 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global HER2 Antibody Market Size by Application (2015-2020)
5.1.1 Global HER2 Antibody Sales by Application (2015-2020)
5.1.2 Global HER2 Antibody Revenue by Application (2015-2020)
5.1.3 HER2 Antibody Price by Application (2015-2020)
5.2 HER2 Antibody Market Size Forecast by Application (2021-2026)
5.2.1 Global HER2 Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global HER2 Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global HER2 Antibody Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America HER2 Antibody by Country
6.1.1 North America HER2 Antibody Sales by Country
6.1.2 North America HER2 Antibody Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America HER2 Antibody Market Facts & Figures by Type
6.3 North America HER2 Antibody Market Facts & Figures by Application
7 EUROPE
7.1 Europe HER2 Antibody by Country
7.1.1 Europe HER2 Antibody Sales by Country
7.1.2 Europe HER2 Antibody Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe HER2 Antibody Market Facts & Figures by Type
7.3 Europe HER2 Antibody Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific HER2 Antibody by Region
8.1.1 Asia Pacific HER2 Antibody Sales by Region
8.1.2 Asia Pacific HER2 Antibody Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific HER2 Antibody Market Facts & Figures by Type
8.3 Asia Pacific HER2 Antibody Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America HER2 Antibody by Country
9.1.1 Latin America HER2 Antibody Sales by Country
9.1.2 Latin America HER2 Antibody Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America HER2 Antibody Market Facts & Figures by Type
9.3 Central & South America HER2 Antibody Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa HER2 Antibody by Country
10.1.1 Middle East and Africa HER2 Antibody Sales by Country
10.1.2 Middle East and Africa HER2 Antibody Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa HER2 Antibody Market Facts & Figures by Type
10.3 Middle East and Africa HER2 Antibody Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech Inc
11.1.1 Genentech Inc Corporation Information
11.1.2 Genentech Inc Description, Business Overview and Total Revenue
11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Inc HER2 Antibody Products Offered
11.1.5 Genentech Inc Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description, Business Overview and Total Revenue
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG HER2 Antibody Products Offered
11.2.5 Novartis AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer HER2 Antibody Products Offered
11.3.5 Pfizer Recent Development
11.4 Abnova Corporation
11.4.1 Abnova Corporation Corporation Information
11.4.2 Abnova Corporation Description, Business Overview and Total Revenue
11.4.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abnova Corporation HER2 Antibody Products Offered
11.4.5 Abnova Corporation Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Corporation Information
11.5.2 InvivoGen Description, Business Overview and Total Revenue
11.5.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 InvivoGen HER2 Antibody Products Offered
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Corporation Information
11.6.2 Celltrion Description, Business Overview and Total Revenue
11.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Celltrion HER2 Antibody Products Offered
11.6.5 Celltrion Recent Development
11.7 Biocon Limited
11.7.1 Biocon Limited Corporation Information
11.7.2 Biocon Limited Description, Business Overview and Total Revenue
11.7.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biocon Limited HER2 Antibody Products Offered
11.7.5 Biocon Limited Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Corporation Information
11.8.2 Bio-Techne Description, Business Overview and Total Revenue
11.8.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bio-Techne HER2 Antibody Products Offered
11.8.5 Bio-Techne Recent Development
11.1 Genentech Inc
11.1.1 Genentech Inc Corporation Information
11.1.2 Genentech Inc Description, Business Overview and Total Revenue
11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Inc HER2 Antibody Products Offered
11.1.5 Genentech Inc Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 HER2 Antibody Market Estimates and Projections by Region
12.1.1 Global HER2 Antibody Sales Forecast by Regions 2021-2026
12.1.2 Global HER2 Antibody Revenue Forecast by Regions 2021-2026
12.2 North America HER2 Antibody Market Size Forecast (2021-2026)
12.2.1 North America: HER2 Antibody Sales Forecast (2021-2026)
12.2.2 North America: HER2 Antibody Revenue Forecast (2021-2026)
12.2.3 North America: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.3 Europe HER2 Antibody Market Size Forecast (2021-2026)
12.3.1 Europe: HER2 Antibody Sales Forecast (2021-2026)
12.3.2 Europe: HER2 Antibody Revenue Forecast (2021-2026)
12.3.3 Europe: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific HER2 Antibody Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: HER2 Antibody Sales Forecast (2021-2026)
12.4.2 Asia Pacific: HER2 Antibody Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: HER2 Antibody Market Size Forecast by Region (2021-2026)
12.5 Latin America HER2 Antibody Market Size Forecast (2021-2026)
12.5.1 Latin America: HER2 Antibody Sales Forecast (2021-2026)
12.5.2 Latin America: HER2 Antibody Revenue Forecast (2021-2026)
12.5.3 Latin America: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa HER2 Antibody Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: HER2 Antibody Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: HER2 Antibody Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: HER2 Antibody Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key HER2 Antibody Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 HER2 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
1.1 HER2 Antibody Product Introduction
1.2 Market Segments
1.3 Key HER2 Antibody Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global HER2 Antibody Market Size Growth Rate by Type
1.4.2 Trastuzumab
1.4.3 Lapatinib
1.4.4 Ado-trastuzumab Emtansine
1.4.5 Pertuzumab
1.4.6 Everolimus
1.5 Market by Application
1.5.1 Global HER2 Antibody Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Medical Center
1.6 Coronavirus Disease 2019 (Covid-19): HER2 Antibody Industry Impact
1.6.1 How the Covid-19 is Affecting the HER2 Antibody Industry
1.6.1.1 HER2 Antibody Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and HER2 Antibody Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for HER2 Antibody Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global HER2 Antibody Market Size Estimates and Forecasts
2.1.1 Global HER2 Antibody Revenue 2015-2026
2.1.2 Global HER2 Antibody Sales 2015-2026
2.2 HER2 Antibody Market Size by Region: 2020 Versus 2026
2.2.1 Global HER2 Antibody Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global HER2 Antibody Retrospective Market Scenario in Revenue by Region: 2015-2020
3 GLOBAL HER2 ANTIBODY COMPETITOR LANDSCAPE BY PLAYERS
3.1 HER2 Antibody Sales by Manufacturers
3.1.1 HER2 Antibody Sales by Manufacturers (2015-2020)
3.1.2 HER2 Antibody Sales Market Share by Manufacturers (2015-2020)
3.2 HER2 Antibody Revenue by Manufacturers
3.2.1 HER2 Antibody Revenue by Manufacturers (2015-2020)
3.2.2 HER2 Antibody Revenue Share by Manufacturers (2015-2020)
3.2.3 Global HER2 Antibody Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by HER2 Antibody Revenue in 2019
3.2.5 Global HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 HER2 Antibody Price by Manufacturers
3.4 HER2 Antibody Manufacturing Base Distribution, Product Types
3.4.1 HER2 Antibody Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers HER2 Antibody Product Type
3.4.3 Date of International Manufacturers Enter into HER2 Antibody Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global HER2 Antibody Market Size by Type (2015-2020)
4.1.1 Global HER2 Antibody Sales by Type (2015-2020)
4.1.2 Global HER2 Antibody Revenue by Type (2015-2020)
4.1.3 HER2 Antibody Average Selling Price (ASP) by Type (2015-2026)
4.2 Global HER2 Antibody Market Size Forecast by Type (2021-2026)
4.2.1 Global HER2 Antibody Sales Forecast by Type (2021-2026)
4.2.2 Global HER2 Antibody Revenue Forecast by Type (2021-2026)
4.2.3 HER2 Antibody Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global HER2 Antibody Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global HER2 Antibody Market Size by Application (2015-2020)
5.1.1 Global HER2 Antibody Sales by Application (2015-2020)
5.1.2 Global HER2 Antibody Revenue by Application (2015-2020)
5.1.3 HER2 Antibody Price by Application (2015-2020)
5.2 HER2 Antibody Market Size Forecast by Application (2021-2026)
5.2.1 Global HER2 Antibody Sales Forecast by Application (2021-2026)
5.2.2 Global HER2 Antibody Revenue Forecast by Application (2021-2026)
5.2.3 Global HER2 Antibody Price Forecast by Application (2021-2026)
6 NORTH AMERICA
6.1 North America HER2 Antibody by Country
6.1.1 North America HER2 Antibody Sales by Country
6.1.2 North America HER2 Antibody Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America HER2 Antibody Market Facts & Figures by Type
6.3 North America HER2 Antibody Market Facts & Figures by Application
7 EUROPE
7.1 Europe HER2 Antibody by Country
7.1.1 Europe HER2 Antibody Sales by Country
7.1.2 Europe HER2 Antibody Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe HER2 Antibody Market Facts & Figures by Type
7.3 Europe HER2 Antibody Market Facts & Figures by Application
8 ASIA PACIFIC
8.1 Asia Pacific HER2 Antibody by Region
8.1.1 Asia Pacific HER2 Antibody Sales by Region
8.1.2 Asia Pacific HER2 Antibody Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific HER2 Antibody Market Facts & Figures by Type
8.3 Asia Pacific HER2 Antibody Market Facts & Figures by Application
9 LATIN AMERICA
9.1 Latin America HER2 Antibody by Country
9.1.1 Latin America HER2 Antibody Sales by Country
9.1.2 Latin America HER2 Antibody Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America HER2 Antibody Market Facts & Figures by Type
9.3 Central & South America HER2 Antibody Market Facts & Figures by Application
10 MIDDLE EAST AND AFRICA
10.1 Middle East and Africa HER2 Antibody by Country
10.1.1 Middle East and Africa HER2 Antibody Sales by Country
10.1.2 Middle East and Africa HER2 Antibody Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa HER2 Antibody Market Facts & Figures by Type
10.3 Middle East and Africa HER2 Antibody Market Facts & Figures by Application
11 COMPANY PROFILES
11.1 Genentech Inc
11.1.1 Genentech Inc Corporation Information
11.1.2 Genentech Inc Description, Business Overview and Total Revenue
11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Inc HER2 Antibody Products Offered
11.1.5 Genentech Inc Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Corporation Information
11.2.2 Novartis AG Description, Business Overview and Total Revenue
11.2.3 Novartis AG Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis AG HER2 Antibody Products Offered
11.2.5 Novartis AG Recent Development
11.3 Pfizer
11.3.1 Pfizer Corporation Information
11.3.2 Pfizer Description, Business Overview and Total Revenue
11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Pfizer HER2 Antibody Products Offered
11.3.5 Pfizer Recent Development
11.4 Abnova Corporation
11.4.1 Abnova Corporation Corporation Information
11.4.2 Abnova Corporation Description, Business Overview and Total Revenue
11.4.3 Abnova Corporation Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Abnova Corporation HER2 Antibody Products Offered
11.4.5 Abnova Corporation Recent Development
11.5 InvivoGen
11.5.1 InvivoGen Corporation Information
11.5.2 InvivoGen Description, Business Overview and Total Revenue
11.5.3 InvivoGen Sales, Revenue and Gross Margin (2015-2020)
11.5.4 InvivoGen HER2 Antibody Products Offered
11.5.5 InvivoGen Recent Development
11.6 Celltrion
11.6.1 Celltrion Corporation Information
11.6.2 Celltrion Description, Business Overview and Total Revenue
11.6.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Celltrion HER2 Antibody Products Offered
11.6.5 Celltrion Recent Development
11.7 Biocon Limited
11.7.1 Biocon Limited Corporation Information
11.7.2 Biocon Limited Description, Business Overview and Total Revenue
11.7.3 Biocon Limited Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Biocon Limited HER2 Antibody Products Offered
11.7.5 Biocon Limited Recent Development
11.8 Bio-Techne
11.8.1 Bio-Techne Corporation Information
11.8.2 Bio-Techne Description, Business Overview and Total Revenue
11.8.3 Bio-Techne Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Bio-Techne HER2 Antibody Products Offered
11.8.5 Bio-Techne Recent Development
11.1 Genentech Inc
11.1.1 Genentech Inc Corporation Information
11.1.2 Genentech Inc Description, Business Overview and Total Revenue
11.1.3 Genentech Inc Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Genentech Inc HER2 Antibody Products Offered
11.1.5 Genentech Inc Recent Development
12 FUTURE FORECAST BY REGIONS (COUNTRIES) (2021-2026)
12.1 HER2 Antibody Market Estimates and Projections by Region
12.1.1 Global HER2 Antibody Sales Forecast by Regions 2021-2026
12.1.2 Global HER2 Antibody Revenue Forecast by Regions 2021-2026
12.2 North America HER2 Antibody Market Size Forecast (2021-2026)
12.2.1 North America: HER2 Antibody Sales Forecast (2021-2026)
12.2.2 North America: HER2 Antibody Revenue Forecast (2021-2026)
12.2.3 North America: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.3 Europe HER2 Antibody Market Size Forecast (2021-2026)
12.3.1 Europe: HER2 Antibody Sales Forecast (2021-2026)
12.3.2 Europe: HER2 Antibody Revenue Forecast (2021-2026)
12.3.3 Europe: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific HER2 Antibody Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: HER2 Antibody Sales Forecast (2021-2026)
12.4.2 Asia Pacific: HER2 Antibody Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: HER2 Antibody Market Size Forecast by Region (2021-2026)
12.5 Latin America HER2 Antibody Market Size Forecast (2021-2026)
12.5.1 Latin America: HER2 Antibody Sales Forecast (2021-2026)
12.5.2 Latin America: HER2 Antibody Revenue Forecast (2021-2026)
12.5.3 Latin America: HER2 Antibody Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa HER2 Antibody Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: HER2 Antibody Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: HER2 Antibody Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: HER2 Antibody Market Size Forecast by Country (2021-2026)
13 MARKET OPPORTUNITIES, CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key HER2 Antibody Players (Opinion Leaders)
14 VALUE CHAIN AND SALES CHANNELS ANALYSIS
14.1 Value Chain Analysis
14.2 HER2 Antibody Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
LIST OF TABLES
Table 1. HER2 Antibody Market Segments
Table 2. Ranking of Global Top HER2 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global HER2 Antibody Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Trastuzumab
Table 5. Major Manufacturers of Lapatinib
Table 6. Major Manufacturers of Ado-trastuzumab Emtansine
Table 7. Major Manufacturers of Pertuzumab
Table 8. Major Manufacturers of Everolimus
Table 9. COVID-19 Impact Global Market: (Four HER2 Antibody Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for HER2 Antibody Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for HER2 Antibody Players to Combat Covid-19 Impact
Table 14. Global HER2 Antibody Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global HER2 Antibody Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global HER2 Antibody Sales by Regions 2015-2020 (K MT)
Table 17. Global HER2 Antibody Sales Market Share by Regions (2015-2020)
Table 18. Global HER2 Antibody Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global HER2 Antibody Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global HER2 Antibody Sales Share by Manufacturers (2015-2020)
Table 21. Global HER2 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global HER2 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibody as of 2019)
Table 23. HER2 Antibody Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. HER2 Antibody Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers HER2 Antibody Price (2015-2020) (USD/MT)
Table 26. HER2 Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers HER2 Antibody Product Type
Table 28. Date of International Manufacturers Enter into HER2 Antibody Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 31. Global HER2 Antibody Sales Share by Type (2015-2020)
Table 32. Global HER2 Antibody Revenue by Type (2015-2020) (US$ Million)
Table 33. Global HER2 Antibody Revenue Share by Type (2015-2020)
Table 34. HER2 Antibody Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 36. Global HER2 Antibody Sales Share by Application (2015-2020)
Table 37. North America HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 38. North America HER2 Antibody Sales Market Share by Country (2015-2020)
Table 39. North America HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 40. North America HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 41. North America HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 42. North America HER2 Antibody Sales Market Share by Type (2015-2020)
Table 43. North America HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 44. North America HER2 Antibody Sales Market Share by Application (2015-2020)
Table 45. Europe HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 46. Europe HER2 Antibody Sales Market Share by Country (2015-2020)
Table 47. Europe HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 49. Europe HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 50. Europe HER2 Antibody Sales Market Share by Type (2015-2020)
Table 51. Europe HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 52. Europe HER2 Antibody Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific HER2 Antibody Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific HER2 Antibody Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific HER2 Antibody Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific HER2 Antibody Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific HER2 Antibody Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific HER2 Antibody Sales Market Share by Application (2015-2020)
Table 61. Latin America HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 62. Latin America HER2 Antibody Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 65. Latin America HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 66. Latin America HER2 Antibody Sales Market Share by Type (2015-2020)
Table 67. Latin America HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 68. Latin America HER2 Antibody Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa HER2 Antibody Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa HER2 Antibody Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa HER2 Antibody Sales Market Share by Application (2015-2020)
Table 77. Genentech Inc Corporation Information
Table 78. Genentech Inc Description and Major Businesses
Table 79. Genentech Inc HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Genentech Inc Product
Table 81. Genentech Inc Recent Development
Table 82. Novartis AG Corporation Information
Table 83. Novartis AG Description and Major Businesses
Table 84. Novartis AG HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Novartis AG Product
Table 86. Novartis AG Recent Development
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Major Businesses
Table 89. Pfizer HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Pfizer Product
Table 91. Pfizer Recent Development
Table 92. Abnova Corporation Corporation Information
Table 93. Abnova Corporation Description and Major Businesses
Table 94. Abnova Corporation HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Abnova Corporation Product
Table 96. Abnova Corporation Recent Development
Table 97. InvivoGen Corporation Information
Table 98. InvivoGen Description and Major Businesses
Table 99. InvivoGen HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. InvivoGen Product
Table 101. InvivoGen Recent Development
Table 102. Celltrion Corporation Information
Table 103. Celltrion Description and Major Businesses
Table 104. Celltrion HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Celltrion Product
Table 106. Celltrion Recent Development
Table 107. Biocon Limited Corporation Information
Table 108. Biocon Limited Description and Major Businesses
Table 109. Biocon Limited HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Biocon Limited Product
Table 111. Biocon Limited Recent Development
Table 112. Bio-Techne Corporation Information
Table 113. Bio-Techne Description and Major Businesses
Table 114. Bio-Techne HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Bio-Techne Product
Table 116. Bio-Techne Recent Development
Table 117. Global HER2 Antibody Sales Forecast by Regions (2021-2026) (K MT)
Table 118. Global HER2 Antibody Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global HER2 Antibody Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global HER2 Antibody Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 122. North America: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 124. Europe: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: HER2 Antibody Sales Forecast by Region (2021-2026) (K MT)
Table 126. Asia Pacific: HER2 Antibody Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 128. Latin America: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 130. Middle East and Africa: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key HER2 Antibody Players
Table 135. HER2 Antibody Customers List
Table 136. HER2 Antibody Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
Table 1. HER2 Antibody Market Segments
Table 2. Ranking of Global Top HER2 Antibody Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global HER2 Antibody Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Trastuzumab
Table 5. Major Manufacturers of Lapatinib
Table 6. Major Manufacturers of Ado-trastuzumab Emtansine
Table 7. Major Manufacturers of Pertuzumab
Table 8. Major Manufacturers of Everolimus
Table 9. COVID-19 Impact Global Market: (Four HER2 Antibody Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for HER2 Antibody Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for HER2 Antibody Players to Combat Covid-19 Impact
Table 14. Global HER2 Antibody Market Size Growth Rate by Application 2020-2026 (K MT)
Table 15. Global HER2 Antibody Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 16. Global HER2 Antibody Sales by Regions 2015-2020 (K MT)
Table 17. Global HER2 Antibody Sales Market Share by Regions (2015-2020)
Table 18. Global HER2 Antibody Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global HER2 Antibody Sales by Manufacturers (2015-2020) (K MT)
Table 20. Global HER2 Antibody Sales Share by Manufacturers (2015-2020)
Table 21. Global HER2 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global HER2 Antibody by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HER2 Antibody as of 2019)
Table 23. HER2 Antibody Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. HER2 Antibody Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers HER2 Antibody Price (2015-2020) (USD/MT)
Table 26. HER2 Antibody Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers HER2 Antibody Product Type
Table 28. Date of International Manufacturers Enter into HER2 Antibody Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 31. Global HER2 Antibody Sales Share by Type (2015-2020)
Table 32. Global HER2 Antibody Revenue by Type (2015-2020) (US$ Million)
Table 33. Global HER2 Antibody Revenue Share by Type (2015-2020)
Table 34. HER2 Antibody Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 35. Global HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 36. Global HER2 Antibody Sales Share by Application (2015-2020)
Table 37. North America HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 38. North America HER2 Antibody Sales Market Share by Country (2015-2020)
Table 39. North America HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 40. North America HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 41. North America HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 42. North America HER2 Antibody Sales Market Share by Type (2015-2020)
Table 43. North America HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 44. North America HER2 Antibody Sales Market Share by Application (2015-2020)
Table 45. Europe HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 46. Europe HER2 Antibody Sales Market Share by Country (2015-2020)
Table 47. Europe HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 49. Europe HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 50. Europe HER2 Antibody Sales Market Share by Type (2015-2020)
Table 51. Europe HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 52. Europe HER2 Antibody Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific HER2 Antibody Sales by Region (2015-2020) (K MT)
Table 54. Asia Pacific HER2 Antibody Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific HER2 Antibody Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific HER2 Antibody Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 58. Asia Pacific HER2 Antibody Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 60. Asia Pacific HER2 Antibody Sales Market Share by Application (2015-2020)
Table 61. Latin America HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 62. Latin America HER2 Antibody Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 65. Latin America HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 66. Latin America HER2 Antibody Sales Market Share by Type (2015-2020)
Table 67. Latin America HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 68. Latin America HER2 Antibody Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa HER2 Antibody Sales by Country (2015-2020) (K MT)
Table 70. Middle East and Africa HER2 Antibody Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa HER2 Antibody Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa HER2 Antibody Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa HER2 Antibody Sales by Type (2015-2020) (K MT)
Table 74. Middle East and Africa HER2 Antibody Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa HER2 Antibody Sales by Application (2015-2020) (K MT)
Table 76. Middle East and Africa HER2 Antibody Sales Market Share by Application (2015-2020)
Table 77. Genentech Inc Corporation Information
Table 78. Genentech Inc Description and Major Businesses
Table 79. Genentech Inc HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 80. Genentech Inc Product
Table 81. Genentech Inc Recent Development
Table 82. Novartis AG Corporation Information
Table 83. Novartis AG Description and Major Businesses
Table 84. Novartis AG HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 85. Novartis AG Product
Table 86. Novartis AG Recent Development
Table 87. Pfizer Corporation Information
Table 88. Pfizer Description and Major Businesses
Table 89. Pfizer HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 90. Pfizer Product
Table 91. Pfizer Recent Development
Table 92. Abnova Corporation Corporation Information
Table 93. Abnova Corporation Description and Major Businesses
Table 94. Abnova Corporation HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 95. Abnova Corporation Product
Table 96. Abnova Corporation Recent Development
Table 97. InvivoGen Corporation Information
Table 98. InvivoGen Description and Major Businesses
Table 99. InvivoGen HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 100. InvivoGen Product
Table 101. InvivoGen Recent Development
Table 102. Celltrion Corporation Information
Table 103. Celltrion Description and Major Businesses
Table 104. Celltrion HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 105. Celltrion Product
Table 106. Celltrion Recent Development
Table 107. Biocon Limited Corporation Information
Table 108. Biocon Limited Description and Major Businesses
Table 109. Biocon Limited HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 110. Biocon Limited Product
Table 111. Biocon Limited Recent Development
Table 112. Bio-Techne Corporation Information
Table 113. Bio-Techne Description and Major Businesses
Table 114. Bio-Techne HER2 Antibody Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 115. Bio-Techne Product
Table 116. Bio-Techne Recent Development
Table 117. Global HER2 Antibody Sales Forecast by Regions (2021-2026) (K MT)
Table 118. Global HER2 Antibody Sales Market Share Forecast by Regions (2021-2026)
Table 119. Global HER2 Antibody Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 120. Global HER2 Antibody Revenue Market Share Forecast by Regions (2021-2026)
Table 121. North America: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 122. North America: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 123. Europe: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 124. Europe: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Asia Pacific: HER2 Antibody Sales Forecast by Region (2021-2026) (K MT)
Table 126. Asia Pacific: HER2 Antibody Revenue Forecast by Region (2021-2026) (US$ Million)
Table 127. Latin America: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 128. Latin America: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 129. Middle East and Africa: HER2 Antibody Sales Forecast by Country (2021-2026) (K MT)
Table 130. Middle East and Africa: HER2 Antibody Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 132. Key Challenges
Table 133. Market Risks
Table 134. Main Points Interviewed from Key HER2 Antibody Players
Table 135. HER2 Antibody Customers List
Table 136. HER2 Antibody Distributors List
Table 137. Research Programs/Design for This Report
Table 138. Key Data Information from Secondary Sources
Table 139. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. HER2 Antibody Product Picture
Figure 2. Global HER2 Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Trastuzumab Product Picture
Figure 4. Lapatinib Product Picture
Figure 5. Ado-trastuzumab Emtansine Product Picture
Figure 6. Pertuzumab Product Picture
Figure 7. Everolimus Product Picture
Figure 8. Global HER2 Antibody Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Medical Center
Figure 11. HER2 Antibody Report Years Considered
Figure 12. Global HER2 Antibody Market Size 2015-2026 (US$ Million)
Figure 13. Global HER2 Antibody Sales 2015-2026 (K MT)
Figure 14. Global HER2 Antibody Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global HER2 Antibody Sales Market Share by Region (2015-2020)
Figure 16. Global HER2 Antibody Sales Market Share by Region in 2019
Figure 17. Global HER2 Antibody Revenue Market Share by Region (2015-2020)
Figure 18. Global HER2 Antibody Revenue Market Share by Region in 2019
Figure 19. Global HER2 Antibody Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by HER2 Antibody Revenue in 2019
Figure 21. HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global HER2 Antibody Sales Market Share by Type (2015-2020)
Figure 23. Global HER2 Antibody Sales Market Share by Type in 2019
Figure 24. Global HER2 Antibody Revenue Market Share by Type (2015-2020)
Figure 25. Global HER2 Antibody Revenue Market Share by Type in 2019
Figure 26. Global HER2 Antibody Market Share by Price Range (2015-2020)
Figure 27. Global HER2 Antibody Sales Market Share by Application (2015-2020)
Figure 28. Global HER2 Antibody Sales Market Share by Application in 2019
Figure 29. Global HER2 Antibody Revenue Market Share by Application (2015-2020)
Figure 30. Global HER2 Antibody Revenue Market Share by Application in 2019
Figure 31. North America HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America HER2 Antibody Sales Market Share by Country in 2019
Figure 34. North America HER2 Antibody Revenue Market Share by Country in 2019
Figure 35. U.S. HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America HER2 Antibody Market Share by Type in 2019
Figure 40. North America HER2 Antibody Market Share by Application in 2019
Figure 41. Europe HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe HER2 Antibody Sales Market Share by Country in 2019
Figure 44. Europe HER2 Antibody Revenue Market Share by Country in 2019
Figure 45. Germany HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 48. France HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe HER2 Antibody Market Share by Type in 2019
Figure 56. Europe HER2 Antibody Market Share by Application in 2019
Figure 57. Asia Pacific HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific HER2 Antibody Sales Market Share by Region in 2019
Figure 60. Asia Pacific HER2 Antibody Revenue Market Share by Region in 2019
Figure 61. China HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 62. China HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 68. India HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific HER2 Antibody Market Share by Type in 2019
Figure 84. Asia Pacific HER2 Antibody Market Share by Application in 2019
Figure 85. Latin America HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America HER2 Antibody Sales Market Share by Country in 2019
Figure 88. Latin America HER2 Antibody Revenue Market Share by Country in 2019
Figure 89. Mexico HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America HER2 Antibody Market Share by Type in 2019
Figure 96. Latin America HER2 Antibody Market Share by Application in 2019
Figure 97. Middle East and Africa HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa HER2 Antibody Sales Market Share by Country in 2019
Figure 100. Middle East and Africa HER2 Antibody Revenue Market Share by Country in 2019
Figure 101. Turkey HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa HER2 Antibody Market Share by Type in 2019
Figure 108. Middle East and Africa HER2 Antibody Market Share by Application in 2019
Figure 109. Genentech Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
Figure 1. HER2 Antibody Product Picture
Figure 2. Global HER2 Antibody Sales Market Share by Type in 2020 & 2026
Figure 3. Trastuzumab Product Picture
Figure 4. Lapatinib Product Picture
Figure 5. Ado-trastuzumab Emtansine Product Picture
Figure 6. Pertuzumab Product Picture
Figure 7. Everolimus Product Picture
Figure 8. Global HER2 Antibody Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Medical Center
Figure 11. HER2 Antibody Report Years Considered
Figure 12. Global HER2 Antibody Market Size 2015-2026 (US$ Million)
Figure 13. Global HER2 Antibody Sales 2015-2026 (K MT)
Figure 14. Global HER2 Antibody Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global HER2 Antibody Sales Market Share by Region (2015-2020)
Figure 16. Global HER2 Antibody Sales Market Share by Region in 2019
Figure 17. Global HER2 Antibody Revenue Market Share by Region (2015-2020)
Figure 18. Global HER2 Antibody Revenue Market Share by Region in 2019
Figure 19. Global HER2 Antibody Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by HER2 Antibody Revenue in 2019
Figure 21. HER2 Antibody Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global HER2 Antibody Sales Market Share by Type (2015-2020)
Figure 23. Global HER2 Antibody Sales Market Share by Type in 2019
Figure 24. Global HER2 Antibody Revenue Market Share by Type (2015-2020)
Figure 25. Global HER2 Antibody Revenue Market Share by Type in 2019
Figure 26. Global HER2 Antibody Market Share by Price Range (2015-2020)
Figure 27. Global HER2 Antibody Sales Market Share by Application (2015-2020)
Figure 28. Global HER2 Antibody Sales Market Share by Application in 2019
Figure 29. Global HER2 Antibody Revenue Market Share by Application (2015-2020)
Figure 30. Global HER2 Antibody Revenue Market Share by Application in 2019
Figure 31. North America HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America HER2 Antibody Sales Market Share by Country in 2019
Figure 34. North America HER2 Antibody Revenue Market Share by Country in 2019
Figure 35. U.S. HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America HER2 Antibody Market Share by Type in 2019
Figure 40. North America HER2 Antibody Market Share by Application in 2019
Figure 41. Europe HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe HER2 Antibody Sales Market Share by Country in 2019
Figure 44. Europe HER2 Antibody Revenue Market Share by Country in 2019
Figure 45. Germany HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 48. France HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe HER2 Antibody Market Share by Type in 2019
Figure 56. Europe HER2 Antibody Market Share by Application in 2019
Figure 57. Asia Pacific HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific HER2 Antibody Sales Market Share by Region in 2019
Figure 60. Asia Pacific HER2 Antibody Revenue Market Share by Region in 2019
Figure 61. China HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 62. China HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 68. India HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific HER2 Antibody Market Share by Type in 2019
Figure 84. Asia Pacific HER2 Antibody Market Share by Application in 2019
Figure 85. Latin America HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America HER2 Antibody Sales Market Share by Country in 2019
Figure 88. Latin America HER2 Antibody Revenue Market Share by Country in 2019
Figure 89. Mexico HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America HER2 Antibody Market Share by Type in 2019
Figure 96. Latin America HER2 Antibody Market Share by Application in 2019
Figure 97. Middle East and Africa HER2 Antibody Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa HER2 Antibody Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa HER2 Antibody Sales Market Share by Country in 2019
Figure 100. Middle East and Africa HER2 Antibody Revenue Market Share by Country in 2019
Figure 101. Turkey HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E HER2 Antibody Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E HER2 Antibody Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa HER2 Antibody Market Share by Type in 2019
Figure 108. Middle East and Africa HER2 Antibody Market Share by Application in 2019
Figure 109. Genentech Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 110. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 111. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 112. Abnova Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 113. InvivoGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 114. Celltrion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 115. Biocon Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 116. Bio-Techne Total Revenue (US$ Million): 2019 Compared with 2018
Figure 117. North America HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. North America HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Europe HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Europe HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Asia Pacific HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 122. Asia Pacific HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 123. Latin America HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 124. Latin America HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 125. Middle East and Africa HER2 Antibody Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 126. Middle East and Africa HER2 Antibody Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 127. Porter's Five Forces Analysis
Figure 128. Channels of Distribution
Figure 129. Distributors Profiles
Figure 130. Bottom-up and Top-down Approaches for This Report
Figure 131. Data Triangulation
Figure 132. Key Executives Interviewed
